Beta Bionics (BBNX) Cash from Financing Activities (2024 - 2026)

Beta Bionics has disclosed Cash from Financing Activities across 3 years of filings, most recently posting $1.8 million for Q2 2026.

• In Q2 2026, Cash from Financing Activities rose 4188.1% year-over-year to $1.8 million; the TTM figure through Jun 2026 stood at $6.1 million (down 97.7% YoY), while the FY2025 annual figure was $214.9 million, up 286.36% from the prior year.
• Cash from Financing Activities came in at $1.8 million for Q2 2026 at Beta Bionics, up from $623000.0 in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $211.1 million in Q1 2025 to a low of -$1.2 million in Q3 2024.
• Average Cash from Financing Activities over 3 years is $27.3 million, with a median of $841500.0 recorded in 2025.
• Year-over-year, Cash from Financing Activities jumped 3518550.0% in 2025 and tumbled 99.7% in 2026.
• Over 3 years, Cash from Financing Activities stood at $56.9 million in 2024, then slumped by 98.14% to $1.1 million in 2025, then surged by 69.91% to $1.8 million in 2026.
• Per Business Quant data, the three most recent Cash from Financing Activities figures were $1.8 million in Q2 2026, $623000.0 in Q1 2026, and $1.1 million in Q4 2025.